治療薬

Japanese Patent JP3947999

B2

It is intended to provide a remedy for diseases caused by macrophages with dysfunction or mediated by macrophages. Namely, a remedy which activates the phagocytic capacity of macrophages and thus is efficiently incorporated into the macrophages due to the vigorous phagocytosis. As a result, the macrophages with dysfunction are normalized, macrophages infected with a pathogen are exterminated or a pathogen in the infected macrophages is exterminated.

WO/2016/104486	METHOD FOR MODIFYING T CELL POPULATION
JP2005231998	METHOD FOR PRODUCING DIALYTIC AMYLOID FIBER POLYMERIZATION NUCLEUS, METHOD FOR SCREENING DIALYTIC AMYLOIDOSIS THERAPEUTIC AGENT AND DIALYTIC AMYLOIDOSIS THERAPEUTIC AGENT
WO/2001/072290	METHOD FOR THE IMPROVEMENT OF ISLET SIGNALING IN DIABETES MELLITUS AND FOR ITS PREVENTION

Hiroshi Terada
Kimiko Makino
Genichiro Sou

JP2004532735A

July 25, 2007

August 27, 2003

Click for automatic bibliography generation  

Hiroshi Terada

A61K45/00; A61K9/14; A61K9/16; A61K9/50; A61K31/00; A61K31/496; A61K31/765; A61K35/74; A61K45/06; A61K47/10; A61K47/24; A61K47/26; A61K47/28; A61K47/32; A61K47/34; A61K47/42; A61P1/04; A61P29/00; A61P31/04; A61P31/06; A61P31/18; A61P33/02; A61P35/00; A61P37/00; A61P37/04; A61P43/00

Sandra SUAREZ,Journal of Antimicrobial Chemotherapy,2001年,Vol.48, No.3,Pages 431-434
Sandra SUAREZ,Pharmaceutical Research,2001年,Vol.18, No.9,Pages 1315-1319
Patrick O'HARA,Pharmaceutical Research,2000年,Vol.17, No.8,Pages 955-961
Esther L. W. BARROW,Antimicrobial Agents and Chemotherapy,1998年,Vol.42, No.10,Pages 2682-2689
Tatiana PUSHKARSKY,Journal of Endotoxin Research,2001年,Vol.7, No.4,Pages 271-276
杣 源一郎,薬学研究の進歩,2000年,Vol.16,Pages 7-22
春日井 尚,帝京医学雑誌,1998年,Vol.21, No.5,Pages 389-402
Rolee SHARMA,Pharmaceutical Research,2001年,Vol.18, No.10,Pages 1405-1410

Kazuo Nakamura

Previous Patent: OUTSIDE HANDLE DEVICE OF AUTOMOBILE TAILGATE

Next Patent: 高熱伝導性部材及びその製造方法ならびにそれを用いた放熱システム